Treatment Guidelines Materials

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies that highlight community advocates’ strategies, achievements, and lessons learned.

This report highlights the work of community-based organizations and people living with HIV/AIDS in advocating for coordinated TB and HIV policies and services in their countries. The report presents case studies from Indonesia, Mexico, Sierra Leon, South Africa, Ukraine, and the Caribbean, highlighting community advocates’ strategies, achievements, and lessons learned.

This document, building on the Stop TB Partnership's first plan for 2001-2005, provides a comprehensive assessment of the action and resources needed to implement the Stop TB strategy and make an impact on the global TB burden. The three components of the plan are strategic directions, global and regional scenarios for TB control, and partnership action to achieve the goals.

This report seeks to synthesize what is known about HIV/AIDS, Malaria, TB and other disease threats including Avian influenza (H5N1 virus) in Burma; assess the regional health and security concerns associated with these epidemics; and to suggest policy options for responding to these threats in the context of tightening restrictions imposed by the junta.

This online resource provides guidelines for general physicians (GPs) about their patients with TB who intend to travel overseas. Issues of concern are the risk of transmission of TB to other passengers, as well as continuity of anti-TB treatment for the patient.

This guideline promotes collaboration between TB and HIV/AIDS programs to reduce the burden for people affected by both diseases.

This guideline promotes collaboration between TB and HIV/AIDS programs to reduce the burden for people affected by both diseases.

This guide assists in making TB control policy decisions and plans for successfully introducing fixed-dose combination drugs (FDCs). This guide is intended for national TB program managers, DOTS strategy implementers, drug procurement officers/personnel, DOT providers, and drug regulatory authorities.

This product will assist health department TB programs to document ways to decrease the number of TB cases. Specifically, programs can identify (1) providers who served the patient up to the TB diagnosis, and (2) points at which the provider failed to carry out TB testing and treatment recommendations. The product includes guidelines for completing the form, displaying data for analysis, and translating data into action.

This book discusses targeted tuberculin skin testing for latent TB infection as a strategic component of TB control. Specifically addressed are how to administer, read, and interpret the tuberculin skin test and its specificity and sensitivity.